RenaudBonnet

Practice Leader Private Equity

Paris + 33.1.56.59.39.14

Conectar

Compartilhe

Renaud Bonnet co-chairs Jones Day's global Private Equity Practice, and his practice areas include venture capital, private equity, M&A, and capital markets. He represents technology and life sciences companies, as well as the private equity and industrial investors that finance them, at every stage of development from entrepreneurial start-ups to multibillion dollar global corporations. He has acted as principal lawyer in a significant number of early to late-stage financing rounds, LBO and other M&A transactions, joint ventures, initial public offerings, rights issues, private placements, and tender offers.

Renaud's recent experience includes representations of technology and life sciences companies Adocia, Advicenne, Ansys, Cellectis, Criteo, Devialet, EcoVadis, HRA Pharma, Ivalua, ManoMano, Mauna Kea Technologies, Nanobiotix, Planisware, Prodways, Sigfox, Talend, TxCell, Voltalia, and Voluntis. His recent investor-side representations include: Abingworth, Alven, Bain Capital Ventures, Bpifrance, Creadev, Danone Ventures, Elaia, Felix Capital, Goldman Sachs, Orange, Hi Inov, Idinvest, Illumina Ventures, Khazana, Seventure, Temasek, and Sofinnova.

Transactions in which Renaud acted as lead lawyer include: representing the issuer and/or underwriters in more than 100 IPOs and follow-on offerings; the IPOs of Criteo, Cellectis, and Talend on Nasdaq; the tender offers on Completel, Wavecom, Assystem, and TxCell; the LBOs of HRA Pharma by Astorg and Goldman Sachs, Orolia by Eurazeo, A2Mac1 by Five Arrows, and Brico Privé by Florac; the sale of Novexel to AstraZeneca and Synthesio to Ipsos; the acquisition of French technology companies by Autodesk, Criteo, SAP, and Ansys; and the latest financing rounds of Devialet, Ivalua, ManoMano, and EcoVadis.

Renaud was a member of the Consultative Commission on Issuers' Transactions and Financial Information of the French Financial Markets Authority (AMF) from 2017 to 2019.

Experiência

  • Institut Pasteur participates in €50 million financing round of Argobio StudioJones Day advised Institut Pasteur in the participation in €50 million round of financing of Argobio Studio, a French company developing projects in biotechnology.
  • Creadev and Temasek lead €140 million Series C financing of InnovaFeedJones Day represented Creadev and Temasek in connection with their participation in a €140 million Series C financing of InnovaFeed, a leader in the rearing of insects for animal feed, on the equity portion representing half of the fundraising value.
  • 360Learning raises $200 million in financing roundJones Day advised 360Learning, a French-based company having developed a collaborative learning SaaS platform to help companies unlock learning based on collective expertise, in connection with its $200 million round of financing led by Sumeru, Silver Lake, and Softbank.
  • ManoMano completes $355 million Series F financing roundJones Day represented ManoMano, an online marketplace specializing in the sale of DIY, home improvement, and gardening products, in connection with its $355 million Series F round of financing led by Dragoneer Investment Group with the participation of existing investors Temasek, General Atlantic, Eurazeo, Bpifrance, Aglaé Ventures, Kismet Holdings, and Armat Group.
  • Goldman Sachs invests in NuxeoJones Day represented Goldman Sachs International in connection with its primary and secondary investment in Nuxeo S.A., a developer of a leading enterprise content management platform which enables organizations to manage complex digital content at massive scale.
  • AccorHotels acquires AvailproJones Day advised AccorHotels, a French multinational hotel group, in connection with its acquisition of Availpro, a leading European software provider to hoteliers.
  • Talend completes IPO of American Depositary Shares on NASDAQJones Day represented Talend SA, a software vendor specializing in big data and cloud integration solutions, in connection with its issuance of $94.5 million of American Depositary Shares in an initial public offering on NASDAQ.
  • BNP Paribas invests in Fortia Financial SolutionsJones Day represented BNP Paribas Securities Services in connection with its investment in Fortia Financial Solutions, a developer and marketer of financial compliance and risk monitoring solutions.
  • Voltalia completes €170 million share capital increaseJones Day represented Voltalia, an international renewable energy producer, in connection with its €170 million (US$188.6 million) share capital increase through a free allotment of warrants to its shareholders and an international offering to institutional investors inside and outside of France.
  • Trace One sold to HgCapitalJones Day advised Trace One SA, a leading Software as a Service (“SaaS”) platform for the retail and private label goods sectors, in connection with its sale to HgCapital.
  • Orolia sold to EurazeoJones Day advised Orolia S.A., a world leader in reliable GPS-type signals, and its main historical shareholder Mr. Laurent Asscher, in connection with Orolia's leveraged buyout with Eurazeo PME.
  • Laboratoire HRA-Pharma sold to Astorg Partners and Goldman SachsJones Day advised Laboratoire HRA-Pharma SAS, a French pharmaceutical company, and its management in connection with its leveraged buy-out by Astorg Partners and Goldman Sachs.
  • HDL Development makes $500 million take-over bid for AssystemJones Day advised HDL Development, a holding company majority owned by Assystem's founding president, in its $500 million take-over bid for Assystem, including the bank financing and guarantee in connection with the bid.
  • Bpifrance and Eurazeo participate in $500 million Series E financing round of ContentsquareJones Day represented Bpifrance and Eurazeo in connection with the $500 million Series E round of financing of Contentsquare, the global leader in digital experience analytics, led by SoftBank Vision Fund 2.
  • Devialet raises €100 million in funding from group of investorsJones Day represented Devialet SA, a market leader in high end amplifiers, in connection with the €100 million (US$106 million) funding from a group of investors including Ginko Ventures, Foxconn Interconnect Technology, Groupe Renault, Sharp Corporation, Playground Global, Naver, Korelya, Roc Nation, Future French Champions, CM-CIC Investissement, and Bpifrance.
  • Bpifrance participates in $220 million financing round of Shift TechnologyJones Day represented Bpifrance in the $220 million round of financing of Shift Technology, a provider of fraud detection and claim automation SAAS solutions for insurance companies.
    •

    March 2023 White Paper

    2022 Annual M&A/PE Review and 2023 Forecast

    December 2022 Webinars

    Webinar Series: Cross-Practice Issues in the Life Sciences

    January 2022 White Paper

    FDI Regimes Continue to Expand and Increase Scrutiny of Transactions Worldwide

    January 2022 White Paper

    2021 Transactional Year in Review and 2022 Forecast

    February 2021 White Paper

    2020 Transactions Year in Review

    August 2019 VIDÉOS

    Jones Day – le bureau de Paris – Sciences de la vie

    June 2016 Alert

    Brexit: United Kingdom Votes to Leave the EU

    Palestras / Aulas

    • 29 janvier 2014
      Le private equity en 2014 : tendances et opportunités
    • 29 janvier 2013
      Le Private Equity : où en sommes-nous ?
    • 20 septembre 2012
      Le financement des PME: actualités juridiques et tendances de marché - en partenariat avec NYSE Euronext et Société Générale
    • September 20, 2012
      SME Financing: legal news and market trends – in collaboration with NYSE Euronext and Société Générale
    • 5 avril 2011
      Atelier « Fusions & Acquisitions » de France Biotech - Le point de vue de l'avocat, intervention de Renaud Bonnet
    • 17 juin 2009
      Introductions en bourse : la mission de l’avocat conseil et la problématique règlementaire, Conférence “Penser à votre introduction en bourse : osé ... mais peut-être astucieux ! ” organisée par la Société Générale
    • 3 avril 2007
      Introductions en bourse : feuille de route pratique
    • 18 mai 2006
      Petit déjeuner thématique "Stock options, BCE, actions gratuites"
    • 14 mars 2006
      Cours à l'ESSEC, "Mécanisme d'incitation des managers"

    Antes de enviar, por favor observe que:

    a Informação contida neste website (www.jonesday.com) destina-se a uso geral e não pode ser considerada como assessoria jurídica. O envio deste e-mail não tem por finalidade criar e seu recebimento não constitui uma relação cliente-advogado. Quaisquer conteúdos enviados para profissionais do Jones Day não são considerados confidenciais ou privilegiados a menos que sejamos seu representante legal. Ao enviar esta mensagem, você confirma que leu e concorda com este aviso.